Clinical Trials · NCT04251156
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 375
- Start date
- Dec 2020
- Locations
- 33 sites, 4 countries
- Primary endpoint
- Change From Baseline in Body Weight (Percentage [%])